FMA
JUNO

FNY Managed Accounts’s Juno Therapeutics, Inc. JUNO Stock Holding History

FNY Managed Accounts’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-73
Closed -$3K – 972
2017
Q4 		$3K Buy
+73
New +$3.64K ﹤0.01% 506

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNY Managed Accounts's JUNO Position: Q1 2018 in Review

FNY Managed Accounts sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 73 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • FNY Managed Accounts reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • FNY Managed Accounts sold 73 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $3K.
  • FNY Managed Accounts first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Juno Therapeutics, Inc. position peaked at $3K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.